Metronidazole USP from Japan
Metronidazole is a synthetic nitroimidazole derivative used primarily as an antibiotic for treating anaerobic bacterial and protozoal infections. It contains an unfused imidazole ring in its structure, qualifying it under HTS 2933.29.90.00 as a heterocyclic compound with nitrogen hetero-atoms only, specifically other unfused imidazole ring compounds.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Provide Certificate of Analysis (COA) confirming purity meets USP standards and imidazole structure verification
• Comply with FDA import requirements including Drug Master File registration for active pharmaceutical ingredients
• Avoid misclassification as finished dosage forms which fall under Chapter 30